Advertisement

Biochemistry and Mechanism of Action of Collagenase on Collagen

  • Marie A. Badalamente
  • Gregory A. Lamaris
Chapter

Abstract

The collagen contents of the Dupuytren contracture lesions have been extensively studied.

Collagen type III is the predominant type of collagen in the early, nodular stages of the disease, while cords mostly contain highly cross-linked collagen type I. In Dupuytren contracture tissues, changes in transforming growth factor beta (TGF-β) signaling pathways promote collagen synthesis and the development of myofibroblasts. If an enzyme is to degrade the triple helix of collagen in the cord, it must first bind to sites on the triple helix, and subsequently unwind it, in order to then cleave one or more strands of the triple helix. Collagenase Clostridium histolyticum performs all three of these activities. Collagenase, after cord injection, is efficiently removed by a plasma protein known as α-2 macroglobulin.

References

  1. 1.
    Lanting R, Broekstra DC, Werker PM, van den Heuvel ER. A systematic review and meta-analysis on the prevalence of Dupupren disease in the genral population of Western countries. Plast Reconstr Surg. 2014;133(3):593–603.CrossRefPubMedGoogle Scholar
  2. 2.
    Luck JV. Dupuytren’s contracture; a new concept of the pathogeneis correlated with surgical management. J Bone Joint Surg Am. 1959;41A(4):635–64.CrossRefGoogle Scholar
  3. 3.
    Brickley-Parsons D, Glimcher MJ, Smith RJ, Albin R, Adams JP. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren’s disease. J Bone Joint Surg Am. 1981;63(5):787–97.CrossRefPubMedGoogle Scholar
  4. 4.
    Lam WL, Rawlins JM, Karoo RO, Naylor I, Sharpe DT. Re-visiting Luck’s classification: a histological analysis of Dupuytren’s disease. J Hand Surg Eur. 2010;35(4):312–7.CrossRefGoogle Scholar
  5. 5.
    Van Beuge MM, Ten Dam EJ, Werker PM, Bank RA. Matrix and cell phenotype differences in Dupuytren's disease. Fibrogenesis Tissue Repair. 2016;29(9):9–12.CrossRefGoogle Scholar
  6. 6.
    Baily AJ, Sims TJ, Gabbani G, Bazin SL, LeLous M. Collagen of Dupuytren’s disease. Clin Sci Mol Med. 1977;53(5):499–502.Google Scholar
  7. 7.
    Arkkilla PE, Koskinen PJ, Kantola IM, Ronnemaa T, Seppanen E, Viikari JS. Dupuytren’s disease in type I diabetic subjects: investigation of biochemical markers of type III and I collagen. Clin Exp Rheumatol. 2000;18(2):215–9.Google Scholar
  8. 8.
    Bazin S, LeLous M, Duance VC, Sims TJ, Bailey AJ, Gabbiani G, D’Andiran G, Pizzolato G, Browski A, Nicoletis C. Biochemistry and histology of the connective tissue of Dupuytren’s disease lesions. Eur J Clin Invest. 1980;10(1):9–16.CrossRefPubMedGoogle Scholar
  9. 9.
    Bowley E, O’Gorman DB, Gan BS. Beta-catenin signaling in fibroproliferative disease. J Surg Res. 2007;138(1):141–50.CrossRefPubMedGoogle Scholar
  10. 10.
    Montgomery E, Lee JH, Abraham SC, Wu TT. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol. 2001;14(7):695–701.CrossRefPubMedGoogle Scholar
  11. 11.
    Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol. 1997;151(2):329–34.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Nagase H, Miyoshi Y, Horii A, Aoki T, Petersen GM, Vogenstein B, Maher E, Ogawa M, Maruyama M, Utsumomiya J. Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat. 1992;1(6):467–73.CrossRefPubMedGoogle Scholar
  13. 13.
    Nakamura Y, Nishisho I, Kinzler KW, Vogelstein B, Miyoshi Y, Miki Y, Ando H, Horii A. Mutations of the APC (adenomatous polyposis coli) gene in FAP (familial Polyposis coli) patients and in sporadic colorectal tumors. Tohoku J Exp Med. 1992;168(2):141–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Abraham SC, Reynolds C, Lee JH, Montgomery EA, Baisden BL, Krasinskas AM, Wu TT. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol. 2002;33(1):39–46.CrossRefPubMedGoogle Scholar
  15. 15.
    Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999;18(47):6615–20.CrossRefPubMedGoogle Scholar
  16. 16.
    Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K. The role of transforming growth factor beta in Dupuytren’s disease. J Hand Surg [Am]. 1996;21(2):210–5.CrossRefGoogle Scholar
  17. 17.
    Berndt A, Kosmehl H, Mandel U, Gabler U, Luo X, Celeda D, Zardi L, Katenkamp D. TGF beta and bFGF synthesis and localization in Dupuytren’s disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J. 1995;27(12):1014–20.CrossRefPubMedGoogle Scholar
  18. 18.
    Varallo VM, Gan BS, Seney S, Ross DC, Roth JH, Richards RS, McFarlane RM, Alman B, Howard JC. Beta-catenin expression in Dupuytren’s disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene. 2003;22(24):3680–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Vi L, Njarlangattil A, Wu Y, Gan BS, O’Gorman DB. Type 1 collagen differentially alters b-catenin accumulation in primary dupuytren’s disease cord and adjacent palmar fascia cells. BMC Musculoskelet Disord. 2009;10:72–5.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Lauer-Fields JL, Juska D, Fields GB. Matrix metalloproteinases and collagen catabolism. Biopolymers. 2002;66:19–32.CrossRefPubMedGoogle Scholar
  21. 21.
    Kono T. Purification and partial characterization of collagenolytic enzymes from Clostridium histolyticum. Biochemistry. 1968;7(3):1106–14.CrossRefPubMedGoogle Scholar
  22. 22.
    Beekman B, Drijfhout JW, Ronday HK, TeKoppele JM. Fluorogenic MMP activity assay for plasma including MMPs complexed to alpha 2-macroglobulin. Ann N Y Acad Sci. 1999;878:150–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of OrthopaedicsStony Brook University Medical CenterStony BrookUSA
  2. 2.Department of Plastic SurgeryThe University of Texas, MD Anderson Cancer CenterHoustonUSA

Personalised recommendations